Keith Lamont Cummings, Chief Financial Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 19,286 shares at $19.10 ($368K) on 2022-12-20, disclosed to the SEC on 2022-12-21.
Open-market sale of $368k PLRX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.10 | 9,643 | $184K | 50.0% |
| 2 | $19.10 | 9,643 | $184K | 50.0% |
| Total | $19.10 avg | 19,286 | $368K | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $252K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $337K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $712K | — | Filing → |